Catalyst Wire Dossier Catalyst Wire Dossier

Hepenofovir Fumarate Tablets (HTS)

Hepenofovir Fumarate · Xi'an Xintong Pharmaceutical Research Co.,Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hepenofovir Fumarate Tablets (HTS), covering 2025-10-02 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II/III of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B [Phase 2, Phase 3]

See pricing